FXR definition
Examples of FXR in a sentence
DSP shall not engage, directly or indirectly, in the commercialization of any other product FXR agonist compound or product in the Field within the Territory.
The FGF1 Licensing Agreement and the FXR Licensing Agreement amend and restate in its entirety that certain Exclusive Patent License Agreement, dated as of January 12, 2015, as amended, by and between Recipient and the Company.
The parties hereby agree that the issuance of the Stock pursuant to this Agreement satisfies all of the Company’s obligations to issue Common Stock of the Company pursuant to Section 4.1 of each of the FGF1 Licensing Agreement and the FXR Licensing Agreement, and after the issuance of the Stock, the Company shall not be obligated to issue any additional Common Stock of the Company pursuant to each of the FGF1 Licensing Agreement and FXR Licensing Agreement.
Metacrine represents and warrants that all of the patents and/or patent applications owned or controlled by Metacrine as of the Amendment Effective Date that cover FXR agonists for diagnosis, prevention and/or treatment of disease in humans are listed in Exhibit G.
FGF-19, a protein secreted from the gut directly under FXR control, with potent metabolic effects (20), showed a similar dose related increase (which may in part explain the weight loss).
FXR agonists have been shown to address three of the most important aspects of ▇▇▇▇ progression by reducing fat, inflammation and fibrosis in the liver.
Obeticholic acid (OCA) is a farnesoid X receptor (FXR) agonist and a modified bile acid that is derived from the primary bile acid chenodeoxycholic acid (CDCA), the natural human FXR ligand.
Two Novartis FXR agonists are now in worldwide clinical studies in ▇▇▇▇ patients.
At the same time, FXR activates BSEP to export BA in the bile, lowering the concentrations in the hepatocytes, and inhibits NTCP and uptake of BA into hepatocytes.
Approximately 5% of bile acids are lost through the faeces each day and replaced by synthesis (▇▇▇▇▇▇ and ▇▇▇▇▇▇▇, 2019) In the liver, bile acid homeostasis is controlled by FXR via SHP, which acts (1) on the uptake of BA by inhibiting the activity of NTCP and (2) on the synthesis of BA with the inhibition of CYP7A1 expression by repressing the hepatocyte nuclear factor 4 α (HNF4α) bound to its promoter (▇▇▇▇▇▇ et al., 2000; ▇▇▇▇▇▇ and ▇▇▇▇▇▇▇, 2019).